Guidelines  ||| S:0 E:11 ||| NNS
for  ||| S:11 E:15 ||| IN
the  ||| S:15 E:19 ||| DT
design ||| S:19 E:25 ||| NN
,  ||| S:25 E:27 ||| ,
conduct  ||| S:27 E:35 ||| NN
and  ||| S:35 E:39 ||| CC
reporting  ||| S:39 E:49 ||| VBG
of  ||| S:49 E:52 ||| IN
human  ||| S:52 E:58 ||| JJ
intervention  ||| S:58 E:71 ||| NN
studies  ||| S:71 E:79 ||| NNS
to  ||| S:79 E:82 ||| TO
evaluate  ||| S:82 E:91 ||| VB
the  ||| S:91 E:95 ||| DT
health  ||| S:95 E:102 ||| NN
benefits  ||| S:102 E:111 ||| NNS
of  ||| S:111 E:114 ||| IN
foods  ||| S:114 E:120 ||| NNS
There  ||| S:120 E:126 ||| EX
is  ||| S:126 E:129 ||| VBZ
substantial  ||| S:129 E:141 ||| JJ
evidence  ||| S:141 E:150 ||| NN
to  ||| S:150 E:153 ||| TO
link  ||| S:153 E:158 ||| VB
what  ||| S:158 E:163 ||| WP
we  ||| S:163 E:166 ||| PRP
eat  ||| S:166 E:170 ||| VBP
to  ||| S:170 E:173 ||| TO
the  ||| S:173 E:177 ||| DT
reduction  ||| S:177 E:187 ||| NN
of  ||| S:187 E:190 ||| IN
the  ||| S:190 E:194 ||| DT
risk  ||| S:194 E:199 ||| NN
of  ||| S:199 E:202 ||| IN
major  ||| S:202 E:208 ||| JJ
chronic  ||| S:208 E:216 ||| JJ
diseases  ||| S:216 E:225 ||| NNS
and ||| S:225 E:228 ||| CC
/ ||| S:228 E:229 ||| NNP
or  ||| S:229 E:232 ||| CC
the  ||| S:232 E:236 ||| DT
improvement  ||| S:236 E:248 ||| NN
of  ||| S:248 E:251 ||| IN
functions ||| S:251 E:260 ||| NNS
.  ||| S:260 E:262 ||| .
Thus ||| S:262 E:266 ||| RB
,  ||| S:266 E:268 ||| ,
it  ||| S:268 E:271 ||| PRP
is  ||| S:271 E:274 ||| VBZ
important  ||| S:274 E:284 ||| JJ
for  ||| S:284 E:288 ||| IN
public  ||| S:288 E:295 ||| JJ
health  ||| S:295 E:302 ||| NN
agencies  ||| S:302 E:311 ||| NNS
and  ||| S:311 E:315 ||| CC
the  ||| S:315 E:319 ||| DT
food  ||| S:319 E:324 ||| NN
industry  ||| S:324 E:333 ||| NN
to  ||| S:333 E:336 ||| TO
facilitate  ||| S:336 E:347 ||| VB
the  ||| S:347 E:351 ||| DT
consumption  ||| S:351 E:363 ||| NN
of  ||| S:363 E:366 ||| IN
foods  ||| S:366 E:372 ||| NNS
with  ||| S:372 E:377 ||| IN
particular  ||| S:377 E:388 ||| JJ
health  ||| S:388 E:395 ||| NN
benefits  ||| S:395 E:404 ||| NNS
by  ||| S:404 E:407 ||| IN
providing  ||| S:407 E:417 ||| VBG
consumer  ||| S:417 E:426 ||| NN
products  ||| S:426 E:435 ||| NNS
and  ||| S:435 E:439 ||| CC
messages  ||| S:439 E:448 ||| NNS
based  ||| S:448 E:454 ||| VBN
on  ||| S:454 E:457 ||| IN
scientific  ||| S:457 E:468 ||| JJ
evidence ||| S:468 E:476 ||| NN
.  ||| S:476 E:478 ||| .
Although  ||| S:478 E:487 ||| IN
fragmentary  ||| S:487 E:499 ||| JJ
advice  ||| S:499 E:506 ||| NN
is  ||| S:506 E:509 ||| VBZ
available  ||| S:509 E:519 ||| JJ
from  ||| S:519 E:524 ||| IN
a  ||| S:524 E:526 ||| DT
range  ||| S:526 E:532 ||| NN
of  ||| S:532 E:535 ||| IN
sources ||| S:535 E:542 ||| NNS
,  ||| S:542 E:544 ||| ,
there  ||| S:544 E:550 ||| EX
is  ||| S:550 E:553 ||| VBZ
a  ||| S:553 E:555 ||| DT
lack  ||| S:555 E:560 ||| NN
of  ||| S:560 E:563 ||| IN
comprehensive  ||| S:563 E:577 ||| JJ
scientific  ||| S:577 E:588 ||| JJ
guidelines  ||| S:588 E:599 ||| NNS
for  ||| S:599 E:603 ||| IN
the  ||| S:603 E:607 ||| DT
design ||| S:607 E:613 ||| NN
,  ||| S:613 E:615 ||| ,
conduct  ||| S:615 E:623 ||| NN
and  ||| S:623 E:627 ||| CC
reporting  ||| S:627 E:637 ||| VBG
of  ||| S:637 E:640 ||| IN
human  ||| S:640 E:646 ||| JJ
intervention  ||| S:646 E:659 ||| NN
studies  ||| S:659 E:667 ||| NNS
to  ||| S:667 E:670 ||| TO
evaluate  ||| S:670 E:679 ||| VB
the  ||| S:679 E:683 ||| DT
health  ||| S:683 E:690 ||| NN
benefits  ||| S:690 E:699 ||| NNS
of  ||| S:699 E:702 ||| IN
foods ||| S:702 E:707 ||| NNS
.  ||| S:707 E:709 ||| .
Such  ||| S:709 E:714 ||| JJ
guidelines  ||| S:714 E:725 ||| NNS
are  ||| S:725 E:729 ||| VBP
needed  ||| S:729 E:736 ||| VBN
both  ||| S:736 E:741 ||| CC
to  ||| S:741 E:744 ||| TO
support  ||| S:744 E:752 ||| VB
nutrition  ||| S:752 E:762 ||| JJ
science  ||| S:762 E:770 ||| NN
in  ||| S:770 E:773 ||| IN
general ||| S:773 E:780 ||| JJ
,  ||| S:780 E:782 ||| ,
and  ||| S:782 E:786 ||| CC
to  ||| S:786 E:789 ||| TO
facilitate  ||| S:789 E:800 ||| VB
the  ||| S:800 E:804 ||| DT
substantiation  ||| S:804 E:819 ||| NN
of  ||| S:819 E:822 ||| IN
health  ||| S:822 E:829 ||| NN
claims ||| S:829 E:835 ||| NNS
.  ||| S:835 E:837 ||| .
In  ||| S:837 E:840 ||| IN
the  ||| S:840 E:844 ||| DT
present  ||| S:844 E:852 ||| JJ
study ||| S:852 E:857 ||| NN
,  ||| S:857 E:859 ||| ,
which  ||| S:859 E:865 ||| WDT
presents  ||| S:865 E:874 ||| VBZ
the  ||| S:874 E:878 ||| DT
consensus  ||| S:878 E:888 ||| NN
view  ||| S:888 E:893 ||| NN
of  ||| S:893 E:896 ||| IN
an  ||| S:896 E:899 ||| DT
International  ||| S:899 E:913 ||| NNP
Life  ||| S:913 E:918 ||| NNP
Sciences  ||| S:918 E:927 ||| NNPS
Institute  ||| S:927 E:937 ||| NNP
Europe  ||| S:937 E:944 ||| NNP
Expert  ||| S:944 E:951 ||| NNP
Group  ||| S:951 E:957 ||| NNP
that  ||| S:957 E:962 ||| WDT
included  ||| S:962 E:971 ||| VBD
senior  ||| S:971 E:978 ||| JJ
scientists  ||| S:978 E:989 ||| NNS
from  ||| S:989 E:994 ||| IN
academia  ||| S:994 E:1003 ||| NN
and  ||| S:1003 E:1007 ||| CC
industry ||| S:1007 E:1015 ||| NN
,  ||| S:1015 E:1017 ||| ,
the  ||| S:1017 E:1021 ||| DT
term  ||| S:1021 E:1026 ||| NN
' ||| S:1026 E:1027 ||| POS
foods ||| S:1027 E:1032 ||| NNS
'  ||| S:1032 E:1034 ||| POS
refers  ||| S:1034 E:1041 ||| NN
to  ||| S:1041 E:1044 ||| TO
foods ||| S:1044 E:1049 ||| NNS
,  ||| S:1049 E:1051 ||| ,
dietary  ||| S:1051 E:1059 ||| JJ
supplements  ||| S:1059 E:1071 ||| NN
and  ||| S:1071 E:1075 ||| CC
food  ||| S:1075 E:1080 ||| NN
constituents ||| S:1080 E:1092 ||| NNS
,  ||| S:1092 E:1094 ||| ,
but  ||| S:1094 E:1098 ||| CC
not  ||| S:1098 E:1102 ||| RB
to  ||| S:1102 E:1105 ||| TO
whole  ||| S:1105 E:1111 ||| JJ
diets ||| S:1111 E:1116 ||| NN
.  ||| S:1116 E:1118 ||| .
The  ||| S:1118 E:1122 ||| DT
present  ||| S:1122 E:1130 ||| JJ
study  ||| S:1130 E:1136 ||| NN
is  ||| S:1136 E:1139 ||| VBZ
based  ||| S:1139 E:1145 ||| VBN
on  ||| S:1145 E:1148 ||| IN
an  ||| S:1148 E:1151 ||| DT
initial  ||| S:1151 E:1159 ||| JJ
survey  ||| S:1159 E:1166 ||| NN
of  ||| S:1166 E:1169 ||| IN
published  ||| S:1169 E:1179 ||| JJ
papers ||| S:1179 E:1185 ||| NNS
,  ||| S:1185 E:1187 ||| ,
which  ||| S:1187 E:1193 ||| WDT
identified  ||| S:1193 E:1204 ||| VBD
the  ||| S:1204 E:1208 ||| DT
range  ||| S:1208 E:1214 ||| NN
and  ||| S:1214 E:1218 ||| CC
strengths  ||| S:1218 E:1228 ||| NNS
and  ||| S:1228 E:1232 ||| CC
weaknesses  ||| S:1232 E:1243 ||| NNS
of  ||| S:1243 E:1246 ||| IN
current  ||| S:1246 E:1254 ||| JJ
methodologies ||| S:1254 E:1267 ||| NNS
,  ||| S:1267 E:1269 ||| ,
and  ||| S:1269 E:1273 ||| CC
was  ||| S:1273 E:1277 ||| VBD
finalised  ||| S:1277 E:1287 ||| VBN
following  ||| S:1287 E:1297 ||| VBG
exchanges  ||| S:1297 E:1307 ||| NNS
between  ||| S:1307 E:1315 ||| IN
representatives  ||| S:1315 E:1331 ||| NNS
from  ||| S:1331 E:1336 ||| IN
industry ||| S:1336 E:1344 ||| NN
,  ||| S:1344 E:1346 ||| ,
academia  ||| S:1346 E:1355 ||| NN
and  ||| S:1355 E:1359 ||| CC
regulatory  ||| S:1359 E:1370 ||| JJ
bodies ||| S:1370 E:1376 ||| NNS
.  ||| S:1376 E:1378 ||| .
The  ||| S:1378 E:1382 ||| DT
major  ||| S:1382 E:1388 ||| JJ
factors  ||| S:1388 E:1396 ||| NNS
involved  ||| S:1396 E:1405 ||| VBN
in  ||| S:1405 E:1408 ||| IN
the  ||| S:1408 E:1412 ||| DT
design ||| S:1412 E:1418 ||| NN
,  ||| S:1418 E:1420 ||| ,
conduct  ||| S:1420 E:1428 ||| NN
and  ||| S:1428 E:1432 ||| CC
reporting  ||| S:1432 E:1442 ||| VBG
of  ||| S:1442 E:1445 ||| IN
studies  ||| S:1445 E:1453 ||| NNS
are  ||| S:1453 E:1457 ||| VBP
identified ||| S:1457 E:1467 ||| VBN
,  ||| S:1467 E:1469 ||| ,
summarised  ||| S:1469 E:1480 ||| VBG
in  ||| S:1480 E:1483 ||| IN
a  ||| S:1483 E:1485 ||| DT
checklist  ||| S:1485 E:1495 ||| JJ
table  ||| S:1495 E:1501 ||| NN
that  ||| S:1501 E:1506 ||| WDT
is  ||| S:1506 E:1509 ||| VBZ
based  ||| S:1509 E:1515 ||| VBN
on  ||| S:1515 E:1518 ||| IN
the  ||| S:1518 E:1522 ||| DT
Consolidated  ||| S:1522 E:1535 ||| NNP
Standards  ||| S:1535 E:1545 ||| NNPS
of  ||| S:1545 E:1548 ||| IN
Reporting  ||| S:1548 E:1558 ||| NNP
Trials  ||| S:1558 E:1565 ||| NNP
guidelines ||| S:1565 E:1575 ||| NNS
,  ||| S:1575 E:1577 ||| ,
and  ||| S:1577 E:1581 ||| CC
elaborated  ||| S:1581 E:1592 ||| NNS
and  ||| S:1592 E:1596 ||| CC
discussed  ||| S:1596 E:1606 ||| VBN
in  ||| S:1606 E:1609 ||| IN
the  ||| S:1609 E:1613 ||| DT
text ||| S:1613 E:1617 ||| NN
.  ||| S:1617 E:1619 ||| .
